• 1
    Frost HM. Bone dynamics in metabolic bone disease. J Bone Joint Surg. 1966; 48(6): 1192.
  • 2
    Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res. 1996; 11(2): 1509.
  • 3
    Parfitt AM. Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone. 2002; 30(6): 8079.
  • 4
    Seeman E, Delmas PD. Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med. 2006; 354(21): 225061.
  • 5
    Hernandez CJ. How can bone turnover modify bone strength independent of bone mass?. Bone. 2008; 42(6): 101420.
  • 6
    Kummari S, Coan T, Hernandez C. Stress concentration factors of remodeling cavities on rod-like and plate-like trabeculae. Presented at: 57th Annual Meeting of the Orthopaedic Research Society; January 13–16, 2011; Long Beach, CA, USA.
  • 7
    Parfitt AM. The physiologic and clinical significance of bone histomorphometric datan. In: Recker RR, editor. Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press; 1983. p. 143223.
  • 8
    Compston J. Bone histomorphometry. In: Arnett T, editor. Methods in bone biology. 1st ed. London: Chapman & Hall; 1997. p. 17797.
  • 9
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2(6): 595610.
  • 10
    Hauge EM, Mosekilde L, Melsen F. Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. J Bone Miner Res. 1994; 26(1): 8990.
  • 11
    Howard CV, Reed MG. Unbiased stereology: three dimensional measurement in microscopy. New York: Springer-Verlag; 1998.
  • 12
    Odgaard A, Andersen K, Melsen F, Gundersen HJ. A direct method for fast three-dimensional serial reconstruction. J Microsc. 1990; 159: 33542.
  • 13
    Beck JD, Canfield BL, Haddock SM, Chen TJ, Kothari M, Keaveny TM. Three-dimensional imaging of trabecular bone using the computer numerically controlled milling technique. Bone. 1997; 21(3): 2817.
  • 14
    Kazakia GJ, Lee JJ, Singh M, Bigley RF, Martin RB, Keaveny TM. Automated high-resolution three-dimensional fluorescence imaging of large biological specimens. J Microsc. 2007; 225(Pt 2): 10917.
  • 15
    Slyfield CR Jr, Niemeyer KE, Tkachenko EV, Tomlinson RE, Steyer GG, Patthanacharoenphon CG, Kazakia GJ, Wilson DL, Hernandez CJ. Three-dimensional surface texture visualization of bone tissue through epifluorescence-based serial block face imaging. J Microsc. 2009; 236(1): 529.
  • 16
    Tkachenko EV, Slyfield CR, Tomlinson RE, Daggett JR, Wilson DL, Hernandez CJ. Voxel size and measures of individual resorption cavities in three-dimensional images of cancellous bone. Bone. 2009; 45(3): 48792.
  • 17
    Li CY, Jee WS, Chen JL, Mo A, Setterberg RB, Su M, Tian XY, Ling YF, Yao W. Estrogen and “exercise” have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat. Calcif Tissue Int. 2003; 72(1): 429.
  • 18
    Jee WSS, Tang L, Ke HZ, Setterberg RB, Kimmel DB. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass. Bone. 1993; 14(3): 4938.
  • 19
    Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res. 2005; 20(2): 17784.
  • 20
    Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: Marcus R, Feldman D, Nelson D, Rosen C, editors. Osteoporosis. 3rd ed., vol. 1. Burlington, MA: Elsevier Academic Press; 2008.
  • 21
    Wronski TJ, Dann LM, Scott KS, Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tiss Int. 1989; 45(6): 3606.
  • 22
    Parfitt AM. Trabecular bone architecture in the pathogenesis and prevention of fracture. Am J Med. 1987; 82(1B): 6872.
  • 23
    van der Linden JC, Verhaar JA, Weinans H. A three-dimensional simulation of age-related remodeling in trabecular bone. J Bone Miner Res. 2001; 16(4): 68896.
  • 24
    Steyer GJ, Roy D, Salvado O, Stone ME, Wilson DL. Removal of out-of-plane fluorescence for single cell visualization and quantification in cryo-imaging. Ann Biomed Eng. 2009; 37(8): 161328.
  • 25
    Marotti G, Zallone A, Ledda M. Number, size and arrangement of osteoblasts in osteons at different stages of formation. Calcif Tiss Int. 1975; 21(1): 96101.
  • 26
    Evans G, Bryant HU, Magee D, Sato M, Turner RT. The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology. 1994; 134(5): 22838.
  • 27
    Recker RR. Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press; 1983.
  • 28
    Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25(7): 146886.
  • 29
    Eriksen EF, Melsen F, Mosekilde L. Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res. 1984; 5(5): 23542.
  • 30
    Hauge EM, Mosekilde L, Melsen F, Frydenberg M. How many patients are needed? Variation and design considerations in bone histomorphometry. Bone. 2001; 28(5): 55662.
  • 31
    Kopperdahl DL, Morgan EF, Keaveny TM. Quantitative computed tomography estimates of the mechanical properties of human vertebral trabecular bone. J Orth Res. 2002; 20(4): 8015.
  • 32
    Bagi CM, Brommage R, Deleon L, Adams S, Rosen D, Sommer A. Benefit of systemically administered rhIGF I and rhIGF I/IGFBP 3 on cancellous bone in ovariectomized rats. J Bone Miner Res. 1994; 9(8): 130112.
  • 33
    Dobnig H, Turner RT. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology. 1995; 136(8): 36328.
  • 34
    Schmidt I, Dobnig H, Turner R. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology. 1995; 136(11): 5127.
  • 35
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats. J Bone Miner Res. 1996; 11(4): 4219.
  • 36
    Frost HM. Bone histomorphometry: correction of the labelling “escape error.” In: Recker RR, editor. Bone histomorphometry: techniques and interpretation. Boca Raton, FL: CRC Press; 1983. p. 13342.
  • 37
    Bell KL, Loveridge N, Reeve J, Thomas CDL, Feik SA, Clement JG. Super-osteons (remodeling clusters) in the cortex of the femoral shaft: influence of age and gender. Anat Rec. 2001; 264(4): 37886.
  • 38
    Parfitt AM. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55(3): 27386.
  • 39
    Jilka R, Hangoc G, Girasole G, Passeri G, Williams D, Abrams J, Boyce B, Broxmeyer H, Manolagas S. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992; 257(5066): 88.
  • 40
    Jilka RL, Passeri G, Girasole G, Cooper S, Abrams J, Broxmeyer H, Manolagas SC. Estrogen loss upregulates hematopoiesis in the mouse: a mediating role of IL-6. Exp Hemat. 1995; 23(6): 500.
  • 41
    Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 1996; 271(46): 28890.
  • 42
    Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-[beta]. Nat Med. 1996; 2(10): 11326.
  • 43
    Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T, Hilton DJ, Suda T, Ng KW, Martin TJ. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med. 1996; 183(6): 258191.
  • 44
    Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007; 130(5): 81123.
  • 45
    Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF. Theoretical perspective: a new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res. 1996; 11(2): 1509.